Tsubura, E <br/><br/>
[The phase I and early phase II studies of human lymphoblast interferon (MOR-22) in the treatment of malignant tumors].  [electronic resource] 

 -  Nihon Gan Chiryo Gakkai shi  Jun 1986 
 - 1049-58 p.  digital 
<br/><br/> Publication Type: English Abstract; Journal Article 
<br/><br/><label>ISSN: </label>0021-4671 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Carcinoma, Renal Cell--drug therapy<br/>Drug Evaluation<br/>Female<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Interferon Type I--adverse effects<br/>Kidney Neoplasms--drug therapy<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Middle Aged